2024-06-29 (六) 15:00 ~ 18:00

2024-06-30 (日) 09:00 ~ 12:00

This forum will focus on the forefront of lung cancer treatment, particularly the latest research and therapeutic strategies for ALK and EGFR mutant non-small cell lung cancer (NSCLC). The forum will present the latest research findings from the ASCO and ELCC meetings, discuss hot topics in lung cancer treatment, and address the clinical challenges faced with patients bearing exon 20 insertion mutations in NSCLC, as well as comprehensive treatment methods for stage III NSCLC. Additionally, the forum will showcase strategies for sequential therapy with Alectinib in advanced ALK mutant NSCLC and early intervention clinical trial results, and will explore the revolutionary advancements in lung cancer diagnosis and treatment brought about by next-generation sequencing (NGS) technology. This forum aims to promote academic exchange and clinical application, bringing new insights and hope to lung cancer diagnosis and treatment.